Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03503097 · ClinicalTrials.gov registry record
Genetic Testing for Men With Metastatic Prostate Cancer
A clinical trial, sponsored by University of Washington.
- Terminated
- Registry status
- 799
- Enrollment target
NCT03503097: Clinical Trial study, sponsored by University of Washington.
NCT03503097 is a clinical trial that was terminated before completion, run by University of Washington. The registered enrollment target is 799 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03503097 was terminated before completion, sponsored by University of Washington.
- TERMINATED
- Registry status
- 799 participants
- Enrollment target
Study Summary
This research study provides genetic testing to men with prostate cancer that has spread to other parts of the body (metastatic prostate cancer) and will look for inherited genetic mutations in about 30 cancer-risk genes. The researchers seek to learn about the participant's opinions and concerns about genetic testing, to determine if this is an acceptable way to deliver testing and to potentially help guide the participant's treatment. Neither treatment nor any decisions related to treatment will take place on this study, but researchers will share each participant's genetic testing results with that participant.
Primary Outcome
Frequency to be determined by genetic testing on saliva samples for inherited mutations in cancer risk genes such as BRCA2, BRCA1, ATM, and others in metastatic prostate cancer.
Interventions
- PROCEDURE Biospecimen Collection
- OTHER Laboratory Biomarker Analysis
- OTHER Genetic Testing
- BEHAVIORAL Questionnaire
- OTHER Genetic Counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 799 participants |
| Start Date | 2017-08-21 |
| Est. Completion | 2025-09-17 |
Why NCT03503097 stopped before completion
NCT03503097 is an observational study that tracks outcomes without assigning an intervention. The registered 799 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 5 interventions - of which Biospecimen Collection is the first listed.
NCT03503097 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03503097 about?
NCT03503097 is a clinical study titled "Genetic Testing for Men With Metastatic Prostate Cancer". This research study provides genetic testing to men with prostate cancer that has spread to other parts of the body (metastatic prostate cancer) and will look for inherited genetic mutations in about 30 cancer-risk genes. The researchers seek to learn about the participant's opinions and concerns ab...
What is the current status of trial NCT03503097?
This trial is currently terminated. The enrollment target is 799 participants. The study started on 2017-08-21. Estimated completion is 2025-09-17.
What interventions are being tested in trial NCT03503097?
The interventions under investigation include: Biospecimen Collection (PROCEDURE), Laboratory Biomarker Analysis (OTHER), Genetic Testing (OTHER), Questionnaire (BEHAVIORAL), Genetic Counseling (OTHER).
Who is sponsoring clinical trial NCT03503097?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00695214 · 800 participants · Phase 2
Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea
- NCT03048201 · 800 participants · NA
Physica System Total Knee Replacement Registry Study
- NCT03792659 · 800 participants
The EXPLORE MG Registry for Myasthenia Gravis
- NCT03819296 · 800 participants · Phase 1
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI